To Study the Efficacy of Chaturjat Pradhaman Nasya and Vyoshadi Vati Orally in Dushtapratishyaya With Special Reference to Chronic Rhinosinusitis.

A Randomized Controlled Clinical Study of Efficacy of Chaturjat Pradhaman Nasya and Vyoshadi Vati Orally in Dushtapratishyaya With Special Reference to Chronic Rhinosinusitis.

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/08/020532

Enrollment

Registered

2019-08-02

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: J018- Other acute sinusitis

Interventions

Intervention1: Chaturjat Pradhaman Nasya and Vyoshadi Vati: Chaturjat Pradhaman Nasya will be given to patient of Dushtapratishyaya of age between 16-60 yrs with dose of 100-300 mg at morning for 5 si

Eligibility

Inclusion criteria

Inclusion criteria: patient having sign and symptoms of chronic rhinosinusitis. patient willing for clinical trial

Exclusion criteria

Exclusion criteria: patient having systemic diseases such as diabetic mellitus,hypertension,ischemic heart disease,organic and infectious disease. nasal disease like DNS,polyp,neoplasms,atrophic rhinitis. congenital anomalies of nose and surroundings

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of chaturjat pradhaman nasya and vyoshadi vati orally in management of Dushtapratishyaya with special reference to chronic rhinosinusitisTimepoint: 15days	—

Secondary

Measure	Time frame
To compare efficacy of chaturjat pradhaman nasya in chronic rhinosinusitis with anutaila. To study the property of chaturjat churna in details.Timepoint: 15days	—

Countries

India

Contacts

Public ContactGayatri Hemraj Bokade

Government ayurved college, vazirabad,nanded,pin-431601

drabdeshmukh@gmail.com9503329622

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026